Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cedars-Sinai researchers identify a gene that causes insulin resistance in Mexican Americans

29.12.2003


A condition linked to heart disease, diabetes, high blood pressure and obesity

For over a decade, scientists have known that insulin resistance - a syndrome where the body does not respond as well as it should to insulin - is linked to the development of heart disease, diabetes, high blood pressure, obesity and polycystic ovary syndrome. In fact, one in four adult Americans has insulin resistance, with Mexican Americans having the highest prevalence. But because people with insulin resistance are so likely to develop diseases such as diabetes and heart disease, scientists have turned their attention on investigating whether a common gene abnormality may be involved.

Now, researchers at Cedars-Sinai Medical Center, in collaboration with investigators at UCLA, have found that lipoprotein lipase (LPL), a gene that controls the delivery of fatty acids to muscle and tissues in the body, is linked to insulin resistance in Mexican-Americans. Their findings, reported in the January issue of Diabetes, may enable scientists to design therapies that target LPL to prevent insulin resistance, a condition estimated to affect over 80 percent of the 16 million Americans with Type 2 diabetes, and additional millions at risk for heart disease.



"This is the first study to definitively show that LPL is a gene for common insulin resistance," said Jerome I. Rotter, M.D., Director of the Division of Medical Genetics and Director of the Common Disease Genetics Program at Cedars-Sinai Medical Center.

In recent years, LPL has emerged as a likely "gene candidate" to study for insulin resistance because some studies had linked it to high blood pressure, obesity, and atherosclerosis (fatty deposits in the arteries) - all of which are associated with the insulin resistance syndrome. But the studies were small, used limited diagnostic tests, and looked at only small portions of the LPL gene.

To determine whether LPL was directly linked to insulin resistance, researchers under Dr. Rotter’s direction, conducted the first study to examine a large, high-risk population of Mexican-Americans using the most precise diagnostic and genetic tests: the glucose clamp, the most precise diagnostic test, coupled with an analysis of the patients’ DNA for a group of six of the most common LPL gene markers in this population called haplotypes. As markers of LPL, these haplotypes function similar to a "bar code" and identify all the major variations or differences of LPL in a population that could be associated with disease. In this study of Mexican-Americans, eight different haplotypes were observed.

In the study, 291 adult-offspring of parents with documented heart disease (112 men and 179 women) were tested for six specific LPL markers and underwent the glucose clamp test receiving an infusion of insulin in one arm over a two-hour period. The patients then also had blood samples drawn from the other arm to determine how much glucose was present in the blood. The patient was found to be less insulin resistant when the samples showed low blood sugar levels even when glucose was added, indicating that the cells were taking up glucose. However, if little or no glucose needed to be added, then the patient was insulin resistant because blood sugar levels were too high, indicating that cells were not using it as they should.

"The glucose clamp technique is considered the ’gold standard’ for testing insulin resistance because it provides the most direct assessment of insulin’s action as opposed to simpler tests that measure glucose or insulin levels while the patient is fasting," commented Dr. Rotter.

To determine whether insulin resistance, as measured by the glucose clamp, was linked to certain variations or haplotypes on the LPL gene, the investigators then examined the level of insulin resistance for each of the eight LPL haplotypes observed in this population. They found that one particular haplotype (designated as Haplotype 4) was associated with a high level of insulin resistance, while another haplotype (Haplotype 1) was linked with low levels of insulin resistance.

"Our study showed that two separate haplotypes of LPL were linked to low or high levels of insulin resistance, confirming that the LPL gene plays a role in determining insulin resistance in this population of Mexican Americans," said Dr. Rotter.

The investigators analyzed larger portions (haplotypes) of the LPL gene, instead of looking at only one or two variations (polymorphisms) in the gene because haplotypes represent the majority of common variation passed down in families, encompassing sections of the gene that have remained unbroken by evolution over time. Consequently, haplotypes are more likely to identify disease associations than single gene variations. Among the 291 patients typed for LPL haplotype markers, 40 patients were found to carry Haplotype 4, the gene marker linked to insulin resistance, while 239 carried Haplotype 1, which is associated with a low level of insulin resistance.

"This finding is significant because it provides direct evidence that LPL is an insulin resistance gene by showing that LPL haplotypes are linked with a direct quantitative measurement of insulin resistance in Mexican Americans," said Dr. Rotter. "The strength of this investigation is that we examined a population at high risk for the insulin resistance syndrome, that we directly measured insulin sensitivity by the glucose clamp study, and that we combined this with the power of a haplotype-based analysis."

Future studies will investigate the actual variation in the LPL gene and how it influences insulin resistance.

Cedars-Sinai Medical Center is one of the largest non-profit academic medical centers in the Western United States. For the fifth straight two-year period, Cedars-Sinai has been named Southern California’s gold standard in health care in an independent survey. Cedars-Sinai is internationally renowned for its diagnostic and treatment capabilities and its broad spectrum of programs and services, as well as breakthrough in biomedical research and superlative medical education. Named one of the 100 "Most Wired" hospitals in health care in 2001, the Medical Center ranks among the top 10 non-university hospitals in the nation for its research activities.

Sandra Van | Van Communications
Further information:
http://www.csmc.edu/

More articles from Health and Medicine:

nachricht FAU researchers demonstrate that an oxygen sensor in the body reduces inflammation
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

nachricht 'Icebreaker' protein opens genome for t cell development, Penn researchers find
21.02.2018 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

The RWI/ISL-Container Throughput Index started off well in 2018

22.02.2018 | Business and Finance

FAU researchers demonstrate that an oxygen sensor in the body reduces inflammation

22.02.2018 | Health and Medicine

Histology in 3D: new staining method enables Nano-CT imaging of tissue samples

22.02.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>